Logotype for Aperam S.A.

Aperam S.A. (APAM) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Aperam S.A.

Q1 2025 earnings summary

24 Dec, 2025

Executive summary

  • Q1 2025 delivered stable results amid a volatile environment, with sales rising to €1,658M and shipments up 14% to 575k tonnes, supported by cost improvements and the Universal acquisition.

  • Universal acquisition closed in January and was fully consolidated from January 23, 2025, expanding the value chain and boosting the Alloys & Specialties segment.

  • Leadership Journey 5 delivered EUR 21 million in Q1, with EUR 116 million cumulative achievements.

  • ESG initiatives advanced, including a EUR 250 million IFC loan for sustainable forest management and decarbonization in Brazil.

  • Net loss of €18M (EPS: -€0.24); pro forma net income excluding Universal was €7M.

Financial highlights

  • Q1 2025 adjusted EBITDA was EUR 86 million, with margin at 5.2% and EBITDA per ton at EUR 200.

  • Sales were EUR 1,658 million, flat year-over-year and up 13% sequentially.

  • Exceptional items totaled negative EUR 36 million, mainly due to Universal acquisition effects.

  • Net financial debt increased to EUR 1,235 million, primarily due to the Universal acquisition and seasonal working capital build-up.

  • Free cash flow was negative, reflecting acquisition and working capital needs.

Outlook and guidance

  • Q2 2025 shipments and adjusted EBITDA expected to be higher sequentially, driven by seasonality, Universal consolidation, and improved volumes.

  • Price pressure in Europe will persist, but Universal will be fully consolidated, supporting EBITDA.

  • Deleveraging to begin in Q2, with net financial debt targeted to normalize by end of 2027.

  • CapEx for 2025 remains at EUR 200 million, focused on maintenance, productivity, and alloys.

  • Dividend policy remains progressive, with a stable base dividend.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more